To be announced
To be announced
To be announced
To be announced
To be announced
NSE/BSE
To be announced
Our Company, Himalaya Nutravedics India Limited (the “Company”), is engaged in the manufacture, marketing and distribution of Ayurvedic and Nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and Nutraceutical companies. Our Company manufactures a diversified portfolio comprising classical (Shastric) Ayurvedic formulati
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 0% | -- |
| Non-Institutional Investors (NIIs) | 0% | -- |
| Retail Individual Investors (RIIs) | 100% | -- |
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| -- | -- | -- |
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 0 shares (aggregating up to To be announced) |
| Fresh Issue | 0 shares (aggregating up to To be announced) |
| Offer for Sale | 0 shares of ₹10 (aggregating up to To be announced) |
| Issue Type | Book building |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 95.14 shares |
| Post-Issue Shareholding | 0 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Himalaya Nutravedics ipo has been designed to ensure broad participation while maintaining optimal price discovery.
Plot No 101 / A Phase- I I I Industrial Development Park Hyderabad
| Book Running Lead Manager(s) |
|---|
| Nirbhay Capital Services Pvt Ltd |